| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6201107 | Ophthalmology | 2014 | 8 Pages |
Abstract
This study represents the overall superiority of low-fluence PDT compared with intravitreal ranibizumab in the treatment of chronic CSC.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
So Hyun MD, Jangwon MD, Cinoo MD, Tae Wan MD, Joo Young MD, Joo Yong MD, Su Jeong MD, Tae Kwann MD, Sang Woong MD, Hum MD,